Appointment Underscores Canton Strategic Holdings' Leadership Role in Accelerating Institutional Adoption of the Canton Network
NEW YORK, March 3, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc., (NASDAQ: CNTN) ("Canton Strategic Holdings" or the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced that Chairman and Chief Executive Officer Mark Wendland has been elected to the Board of Directors (the "Board") of the Canton Foundation (the "Foundation"). Mr. Wendland joins 17 existing Board members, including senior leaders from DTCC, Euroclear, HSBC, Digital Asset, Broadridge, and other global financial institutions, with Canton Strategic Holdings becoming a Member of the Foundation.
The Canton Foundation serves as the independent governance body responsible for overseeing the operation, standards, and validator framework of the Canton Network, including policies related to the Global Synchronizer and broader network operations. Mr. Wendland's appointment reflects Canton Strategic Holdings' continued alignment with the Foundation's mission to foster the development and growth of the Global Synchronizer in the Canton Network and facilitate its governance as institutional adoption as the ecosystem scales.
"The Canton Network's governance model is central to its institutional credibility," said Mark Wendland, Chairman and CEO of Canton Strategic Holdings, Inc. "Widespread adoption depends on strong, transparent oversight and disciplined standards that ensure technological resilience, interoperability, and long-term sustainability. The Foundation plays a critical role in upholding that framework, and I am honored to join the Board at this pivotal moment as the Canton Network increasingly becomes foundational infrastructure for modern financial markets."
About Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. (NASDAQ: CNTN), is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company also operates clinical-stage biotech research and development. For more information, visit www.cantonstrategic.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.
Canton is a registered trademark of Digital Asset (Switzerland) GmbH. Digital Asset is not affiliated with, and has not sponsored or endorsed, the operations of Canton Strategic Holdings, Inc.
Contacts
Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com
Investors:
ir@cantonstrategic.com
X: @CantonStrategic
LinkedIn: Linkedin.com/CantonStrategicHoldings
Website: www.cantonstrategic.com
Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update
Comprehensive Report Outlines Adoption Milestones, Onchain Transaction Growth, and Key Infrastructure Developments Across the Canton Network in Q1 2026
March 31, 2026Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results
First Annual Report Since Establishing Canton Network Digital Asset Strategy Highlights Accelerating Network Momentum and Strengthened Capital Position
March 3, 2026Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board
Appointment Underscores Canton Strategic Holdings' Leadership Role in Accelerating Institutional Adoption of the Canton Network
February 17, 2026Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy
New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026; Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction Volume
February 6, 2026Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the...
February 2, 2026Tharimmune Elects Jill Sommers and William Wiley to Board of Directors
Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the...
January 26, 2026Tharimmune Announces Expanded Role as Super Validator on Canton Network
Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the...
January 22, 2026Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize...
January 20, 2026Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize...
December 18, 2025Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network
Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize...
November 13, 2025Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids
Tharimmune, Inc. (Nasdaq: THAR) ("Tharimmune" or the "Company"), a digital asset treasury company with a clinical-stage biotechnology function, today ...
November 6, 2025Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy
Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), a publicly traded company that will leverage the Canton Coin ("CC") to support the...
November 3, 2025Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy
Other Participants Include ARK Invest, Bitwave, Broadridge, Clear Street, Copper, Digital Asset, Feynman Point Asset Management, Five North, Kaiko,...
